Biomarin Pharmaceutical shares owned by Simplex Trading
Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Simplex Trading
from 13F filings
Historical chart of Simplex Trading investment in Biomarin Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Biomarin Pharmaceutical held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biomarin Pharmaceutical by Simplex Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $3.4M | 39k | 87.33 |
| 2023-12-31 | $5.1M | 53k | 96.40 |
| 2023-09-30 | $5.2M | 59k | 88.46 |
| 2023-06-30 | $8.2M | 95k | 86.67 |
| 2023-03-31 | $4.8M | 49k | 97.24 |
| 2022-12-31 | $7.9M | 77k | 103.49 |
| 2022-09-30 | $5.2M | 61k | 84.76 |
| 2022-06-30 | $3.6M | 44k | 82.85 |
| 2022-03-31 | $2.4M | 32k | 77.08 |
| 2021-12-31 | $2.9M | 35k | 83.89 |
| 2021-09-30 | $2.9M | 35k | 83.89 |
| 2021-06-30 | $2.9M | 35k | 83.43 |
| 2021-03-31 | $5.7k | 752 | 7.55 |
| 2020-12-31 | $18k | 2.0k | 8.77 |
| 2020-09-30 | $7.7k | 1.0k | 7.61 |
| 2020-06-30 | $6.5k | 528 | 12.33 |
| 2020-03-31 | $4.1k | 491 | 8.45 |
| 2019-12-31 | $2.9k | 338 | 8.45 |
| 2019-09-30 | $1.8k | 264 | 6.74 |
| 2019-06-30 | $1.5k | 176 | 8.56 |
| 2019-03-31 | $718 | 81 | 8.88 |
| 2018-12-31 | $1.3k | 154 | 8.51 |
| 2018-09-30 | $1.7k | 178 | 9.70 |
| 2018-06-30 | $3.2k | 343 | 9.42 |
| 2018-03-31 | $23k | 63 | 365.08 |
| 2017-12-31 | $61k | 158 | 386.08 |
| 2017-09-30 | $92k | 142 | 647.89 |
| 2017-06-30 | $25k | 79 | 316.46 |
| 2017-03-31 | $34k | 115 | 295.65 |
| 2016-12-31 | $78k | 166 | 469.88 |
| 2016-09-30 | $56k | 239 | 234.31 |
| 2016-06-30 | $23k | 366 | 62.84 |
| 2016-03-31 | $141k | 438 | 321.92 |
| 2015-12-31 | $206k | 231 | 891.77 |
| 2015-09-30 | $175k | 530 | 330.19 |
| 2015-06-30 | $553k | 330 | 1675.76 |
| 2015-03-31 | $969k | 367 | 2640.33 |
| 2014-12-31 | $398k | 191 | 2083.77 |
Top funds holding Biomarin Pharmaceutical
View all funds holding Biomarin Pharmaceutical